Funding Opportunities

Grants for melanoma and skin cancer clinical research

Melanoma and Skin Cancer Trials conducts investigator-initiated clinical trials and related research to improve how doctors prevent, diagnose and treat melanoma and skin cancer.

We have built an impressive reputation for delivering multicentre trials that improve melanoma and skin cancer outcomes across the world. Since 1999, we have delivered 29 clinical trials involving over 7,500 participants.

Melanoma and Skin Cancer Trials facilitates the development of competitive investigator-initiated proposals through our concept development pathway. For more information on how we can help you develop a research proposal and secure funding, contact us.

2024 Independent Research Institutes Infrastructure Support Scheme (IRIISS) - GO7111

Open Date

14 August 2024

Closing Date

25 September 2024

Grant amount

$32,000,000 AUD (Total amount available)

Application website

2024 Independent Research Institutes Infrastructure Support Scheme (IRIISS)

About

IRIISS allocates funds for infrastructure support to independent medical research institutes managing NHMRC research funds.

IRIISS aims to develop and maintain infrastructure to support high quality health and medical research by contributing to infrastructure costs associated with competitively awarded NHMRC research grants managed by independent medical research institutes.

Quality Use of Diagnostics, Therapeutics and Pathology Program - Health Professional Education - GO7119

Open Date

22 August 2024

Closing Date

14 October 2024

Grant amount

$32,742,000 AUD (Total amount available)

Application website

Quality Use of Diagnostics, Therapeutics and Pathology Program – Health Professional Education

About

The Health Professional Education grant opportunity (the grant opportunity) is targeted towards supporting the Quality Use of Medicine (QUM) educational needs of health professionals. The grant opportunity can also support quality use of diagnostics and pathology which leads to improved QUM outcomes. This grant opportunity supports synergies across the healthcare system, leveraging the grant funding to achieve shared QUM goals through the provision of evidence-based QUM initiatives. This grant opportunity will require high levels of collaboration and cooperation between relevant stakeholders to achieve the intended grant outcomes.

Quality Use of Diagnostics, Therapeutics and Pathology: Consumer Health Literacy Grant Opportunity - GO7118

Open Date

22 August 2024

Closing Date

15 October 2024

Grant amount

$6,186,675 AUD (Total amount available)

Application website

Quality Use of Diagnostics, Therapeutics and Pathology: Consumer Health Literacy Grant Opportunity

About

The Consumer Health Literacy grant opportunity (the grant opportunity) is aimed towards improving and supporting medication health literacy for Australians. The grant opportunity can also support quality use of diagnostics and pathology which leads to improved QUM outcomes. This grant opportunity will require high levels of collaboration and cooperation between relevant QUM stakeholders to achieve the intended grant outcomes.

NHMRC-EU Collaborative Research Grant Scheme 2024 - GO6361

Open Date

12 July 2023

Closing Date

16 October 2024

Grant amount

$1,000,000 AUD (Total amount available: $4,000,000 AUD)

Application website

NHMRC-EU Collaborative Research Grant Scheme 2024

About

The NHMRC-European Union (EU) Collaborative Research Grant Scheme supports Australian participation in international collaborative research under Horizon Europe. Horizon Europe facilitates collaboration and strengthens research impact and innovation while tackling global challenges.

Projects involving Australian-based researchers chosen by the EU for funding may be eligible for NHMRC support. NHMRC is considering supporting Australian researchers for the below Horizon Europe submitted through the two-stage deadline model:

  • HORIZON-HLTH-2024-STAYHLTH-01-05-two-stage: Personalised prevention of non-communicable diseases – addressing areas of unmet need using multiple data sources
  • HORIZON-HLTH-2024-ENVHLTH-02-06-two-stage: The role of environmental pollution in non-communicable diseases: air, noise, and light, and hazardous waste pollution
  • HORIZON-HLTH-2024-DISEASE-03-08-two-stage: Comparative effectiveness research for healthcare interventions in areas of high public health need
  • HORIZON-HLTH-2024-DISEASE-03-11-two-stage: Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness

and submitted through the single-stage deadline model:

  • HORIZON-HLTH-2024-DISEASE-08-20: Pandemic preparedness and response: Host pathogen interactions for infectious diseases with epidemic potential

2024 Partnerships for culturally safe cancer care grant program - GO7058

Open Date

23 July 2023

Closing Date

23 October 2024

Grant amount

$1,000,000 AUD (Total amount: $16,875,000 AUD)

Application website

2024 Partnerships for culturally safe cancer care grant program

About

The grant program aims to support implementation of innovative approaches to accelerate the delivery of culturally safe, accessible, and responsive cancer care for Aboriginal and Torres Strait Islander people.

MRFF 2024 Research Data Infrastructure Grant Opportunity - GO6960

Open Date

15 July 2023

Closing Date

28 October 2024

Grant amount

$2,500,000 AUD (Total amount available $10,000,000 AUD)

Application website

MRFF 2024 Research Data Infrastructure Grant Opportunity

About

This grant opportunity is part of the Medical Research Future Fund and the Research Data Infrastructure Initiative. It looks to fund the creation or extension of national research data infrastructure to support world-class health and medical research in Australia.

Research proposals should incorporate:

  • New linkage and/or use of data from multiple (at least two) existing research data infrastructure sources of different types (e.g. administrative and biobank data, registry and biobank data, wearables and use artificial intelligence); and/or
  • Novel methodologies and approaches that leverage and enhance existing linked research data infrastructure of at least two different types (e.g. administrative and biobank data, registry and biobank data, wearables and use artificial intelligence); and
  • A clear outline of how the proposed project will produce knowledge and outcomes that address and area of unmet medical need.

NHMRC Partnership Projects 2024 - GO6697

Open Date

  • PRC2: 21 March 2024
  • PRC3: 25 July 2024

Closing Date

  • PRC2: 24 July 2024
  • PRC3: 13 November 2024

Grant amount

$1,500,000 AUD (Total amount: $31,600,000 AUD)

Application website

NHMRC Partnership Projects

About

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.

The objectives of the Partnership Project scheme are to:

  • Meet the need for more effective integration of research evidence into health policy and service delivery
  • Create partnerships among policy makers, managers, service providers and researchers
  • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians health and health care
  • Be highly responsive to the priorities of government, the community and health professionals
  • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

NHMRC Partnership Projects 2024 - GO6697

Open Date

10 January 2024

Closing Date

27 November 2024

Grant amount

$1,500,000 AUD (Total amount available $31,600,000 AUD)

Application website

NHMRC Partnership Projects 2024

About

Partnership Projects will support collaborations, within the Australian context, that translate research evidence into health policy and health practice, to improve health services and processes.

The objectives of the Partnership Project scheme are to:

  • Meet the need for more effective integration of research evidence into health policy and service delivery
  • Create partnerships among policy makers, managers, service providers and researchers
  • Provide support to answer often complex and difficult questions that policy makers, managers and service providers face when making decisions and implementing policies that affect Australians health and health care
  • Be highly responsive to the priorities of government, the community and health professionals
  • Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations.

MRFF - 2024 International Clinical Trial Collaborations Grant Opportunity - GO6825

Open Date

6 March 2024

Closing Date

5 February 2025

Grant amount

$3,000,000 AUD (Total amount available $12,600,000 AUD)

Application website

MRFF 2024 International Clinical Trial Collaborations Grant Opportunity

About

The Clinical Trials Activity Initiative (the Initiative) aims to:

  • Improve the evidence base supporting clinical care
  • Help patients access trials relevant to their health circumstances
  • Enable researchers to bring international trials to Australian patients

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

  • Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
  • Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.

MRFF 2024 National Critical Research Infrastructure Grant Opportunity - MRFF 2024 NCRII

Open Date

4 October 2024

Closing Date

31 March 2025

Grant amount

$7,000,000 AUD

Application website

MRFF 2024 National Critical Research Infrastructure Grant Opportunity

About

The 2024 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams.

Stream 1 – Innovation enablers: Addresses an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks, tissue repositories, novel research platforms, and secure health data environments to create valuable research resources.

Stream 2 – Digitisation of health care: Developing and translating into practice digital therapeutics, artificial intelligence enabled health interventions and technologies (e.g. wearables integrated into clinical practice), applications or other software for use in clinical practice.

Stream 3 – Co-investment partnerships: Utilising co-investment (cash only) with the research sector, state and/or territory governments, and industry, in significant critical research infrastructure (e.g. facilities, personnel and equipment).

Stream 4 – mRNA technology enablers: Leveraging and enhancing emerging mRNA technologies, platforms, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need.

MRFF 2024 Clinical Trials Activity Grant Opportunity - GO7146

Open Date

4 September 2024

Closing Date

2 April 2025

Grant amount

$5,000,000 AUD (Total amount: $63,000,000 AUD)

Application website

MRFF 2024 Clinical Trials Activity Grant Opportunity

About

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

  • Stream 1 (Targeted Call for Research): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer, rare disease and/or unmet need.
  • Stream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers, rare diseases and/or unmet need.
  • Stream 3 (Targeted Call for Research): conduct a clinical trial that assesses the comparative effectiveness of two or more health interventions to treat a specific clinical condition, to inform the decisions of policy makers, clinicians, and consumers regarding healthcare and to minimise the use of unnecessary, ineffective, and harmful health interventions.
  • Stream 4 (Targeted Call for Research): conduct an implementation science trial to determine the best ways to implement a proven preventive health intervention, screening or diagnostic test, therapeutic agent, technology or model of care that is not in routine use in Australia.

Cancer Patient Care Program - GO6736

Open Date

2 April 2024

Closing Date

1 August 2025

Grant amount

$1,000,000 AUD (Total amount available $16,500,000 AUD)

Application website

Cancer Patient Care Program

About

This grant opportunity seeks to ensure that all Australian’s living with cancer have access to high-quality and culturally safe support throughout their cancer experience. Acknowledging the existing national cancer screening programs and funding provided for more commonly diagnosed cancers, this grant opportunity will prioritise activities that focus on increasing equity across tumour types and/or priority populations.

The Cancer Patient Support Program (the Program) will support, one-off, time-limited activities that provide national leadership on emerging priorities across the cancer control continuum.

MRFF 2022 Frontier Health and Medical Research Grant Opportunity - GO5855

Open Date

13 February 2023

Closing Date

31 March 2026

Grant amount

$25,000,000 AUD (Total amount: $40,000,000 AUD)

Application website

MRFF 2022 Frontier Health and Medical Research Grant Opportunity

About

This grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re-purpose existing health technologies in a novel way.